Cheryl Eifert

435 total citations
12 papers, 296 citations indexed

About

Cheryl Eifert is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Cheryl Eifert has authored 12 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cancer Research and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Cheryl Eifert's work include Cancer Genomics and Diagnostics (4 papers), RNA Interference and Gene Delivery (2 papers) and Genetic factors in colorectal cancer (2 papers). Cheryl Eifert is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), RNA Interference and Gene Delivery (2 papers) and Genetic factors in colorectal cancer (2 papers). Cheryl Eifert collaborates with scholars based in United States. Cheryl Eifert's co-authors include Scott Powers, Antonis Kourtidis, Douglas S. Conklin, Ritu Jain, M. Julia Brosnan, Jane F. Koretz, Michael J. Gerdes, Xianhui Wang, Leila Kokabee and Ritu Jain and has published in prestigious journals such as Journal of Clinical Oncology, Nature reviews. Cancer and Cancer Research.

In The Last Decade

Cheryl Eifert

12 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheryl Eifert United States 9 188 89 69 43 42 12 296
Padma L. Channavajhala United States 9 292 1.6× 44 0.5× 92 1.3× 29 0.7× 34 0.8× 9 372
Summanuna H. Togo United States 6 386 2.1× 66 0.7× 85 1.2× 34 0.8× 36 0.9× 7 454
Tatiana Erazo Spain 11 287 1.5× 34 0.4× 72 1.0× 18 0.4× 15 0.4× 15 374
Matheus Henrique Dias Brazil 11 198 1.1× 55 0.6× 53 0.8× 9 0.2× 25 0.6× 23 318
Catherine Neary United States 9 279 1.5× 70 0.8× 78 1.1× 7 0.2× 28 0.7× 9 376
Mengtao Xiao China 3 411 2.2× 84 0.9× 49 0.7× 21 0.5× 34 0.8× 7 573
Bryan Deans United Kingdom 7 474 2.5× 130 1.5× 116 1.7× 42 1.0× 58 1.4× 8 551
Lian Mignacca Canada 8 259 1.4× 109 1.2× 92 1.3× 17 0.4× 13 0.3× 10 358
Cathleen Brdlik United States 8 264 1.4× 40 0.4× 179 2.6× 18 0.4× 16 0.4× 10 457

Countries citing papers authored by Cheryl Eifert

Since Specialization
Citations

This map shows the geographic impact of Cheryl Eifert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl Eifert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl Eifert more than expected).

Fields of papers citing papers by Cheryl Eifert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl Eifert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl Eifert. The network helps show where Cheryl Eifert may publish in the future.

Co-authorship network of co-authors of Cheryl Eifert

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl Eifert. A scholar is included among the top collaborators of Cheryl Eifert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl Eifert. Cheryl Eifert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Eifert, Cheryl, Angeliki Pantazi, Ruobai Sun, et al.. (2017). Clinical Application of a Cancer Genomic Profiling Assay to Guide Precision Medicine Decisions. Personalized Medicine. 14(4). 309–325. 23 indexed citations
3.
Vuzman, Dana, Ruobai Sun, Cheryl Eifert, et al.. (2017). Tumor mutation burden derived from large NGS panel as biomarker for immunotherapy response.. Journal of Clinical Oncology. 35(15_suppl). e23077–e23077. 4 indexed citations
4.
Sun, Ruobai, Pablo Cingolani, Angeliki Pantazi, et al.. (2017). Germline and somatic SNVS calling in NGS panel tumor samples: Approaches to optimize tumor only genomic analysis for cancer precision medicine.. Journal of Clinical Oncology. 35(15_suppl). e13011–e13011. 1 indexed citations
5.
Eifert, Cheryl, Xianhui Wang, Leila Kokabee, et al.. (2013). A novel isoform of the B cell tyrosine kinase BTK protects breast cancer cells from apoptosis. Genes Chromosomes and Cancer. 52(10). 961–975. 48 indexed citations
6.
Eifert, Cheryl & Scott Powers. (2012). From cancer genomes to oncogenic drivers, tumour dependencies and therapeutic targets. Nature reviews. Cancer. 12(8). 572–578. 67 indexed citations
7.
8.
Eifert, Cheryl. (2009). An RNAi screen targeting the protein tyrosine kinases identifies Bruton's tyrosine kinase (BTK) as a breast cancer cell survival factor. Scholars Archive - University at Albany (University at Albany, State University of New York). 1 indexed citations
9.
Kourtidis, Antonis, Cheryl Eifert, & Douglas S. Conklin. (2007). RNAi Applications in Target Validation. PubMed. 1–21. 9 indexed citations
10.
Eifert, Cheryl, Niquiche Sangster‐Guity, Liming Yu, et al.. (2006). Global gene expression profiles associated with retinoic acid‐induced differentiation of embryonal carcinoma cells. Molecular Reproduction and Development. 73(7). 796–824. 30 indexed citations
11.
Eifert, Cheryl, et al.. (2005). N-terminal control of small heat shock protein oligomerization: changes in aggregate size and chaperone-like function. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1748(2). 146–156. 23 indexed citations
12.
Salerno, J.C., et al.. (2003). Structural diversity in the small heat shock protein superfamily: control of aggregation by the N-terminal region. Protein Engineering Design and Selection. 16(11). 847–851. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026